LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,463,585 | $6,744,907 | $9,927,109 | $18,839,565 |
| - Cash | $665,755 | $979,312 | $833,792 | $1,119,264 |
| + Debt | $4,979 | $9,296 | $9,674 | $15,671 |
| Enterprise Value | $6,802,809 | $5,774,891 | $9,102,991 | $17,735,972 |
| Revenue | $1,303,699 | $1,267,175 | $1,097,310 | $925,334 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Gross Profit | $981,435 | $995,637 | $873,928 | $747,534 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| EBITDA | $288,881 | $253,462 | $445,784 | $397,588 |
| % Margin | 22.2% | 20% | 40.6% | 43% |
| Net Income | $222,388 | $263,242 | $325,337 | $292,472 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| % Growth | -13.9% | -20% | 15.6% | – |
| Operating Cash Flow | $321,460 | $418,049 | $388,318 | $488,853 |
| Capital Expenditures | -$283,001 | -$292,687 | -$335,473 | -$343,285 |
| Free Cash Flow | $38,459 | $125,362 | $52,845 | $145,568 |